AI-Derived Model Identifies Prostate Cancer Patients Likely to Benefit From ADT
An artificial intelligence (AI)-derived model can identify prostate cancer patients who are likely to benefit from short-term [...]
AI May Predict Benefit with Hormone Therapy Plus Radiotherapy in Prostate Cancer
Artificial intelligence (AI) may predict which patients with intermediate-risk prostate cancer will benefit from short-term a [...]
Novel AI Model Predicts ADT Benefit in Patients With Prostate Cancer
Results of a phase 3 randomized trial published in NEJM Evidence suggest a novel artificial intelligence (AI) model may help [...]
ArteraAI Announces First-Ever AI-Derived Biomarker for Predicting Androgen Deprivation Therapy (ADT) Benefit in Prostate Cancer
ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announced today t [...]
Florida medical tech company launches novel AI test for prostate cancer therapy
ArteraAI’s ‘first-ever predictive test’ helps doctors choose personalized treatment for patients Fox News Article
Can Artificial Intelligence Help Diagnose Prostate Cancer?
AI may be a medical game-changer, with the power of machine learning advancing the efficacy of prostate cancer biopsies and m [...]
Andre Esteva of ArteraAI: 5 Things I Wish Someone Told Me Before I Became A CEO
Medium’s Doug Noll spoke with the CEO of ArteraAI, Andre Esteva, to discuss his path from Stanford University to founding fou [...]
ArteraAI and ACS form collaboration to use AI for designing personalized therapy
ArteraAI and the American Cancer Society formed a collaboration focused on the development of AI-driven cancer therapy person [...]
ArteraAI and American Cancer Society Announce New Relationship
ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American [...]